FDA Adverse Event Malfunction Summary report: N

ACCESS

MDR report key: 2851431 · Received November 29, 2012

Report

Report Number
1416980-2012-06146
Event Type
Malfunction
Date Received
November 29, 2012
Date of Event
November 6, 2012
Report Date
November 6, 2012
Manufacturer
BAXTER HEALTHCARE
Product Code
FPA
PMA / PMN Number
K112893
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE SAMPLE IS REPORTED TO BE AVAILABLE FOR EVALUATION. IF THE SAMPLE IS RECEIVED OR ADDITIONAL INFORMATION BECOMES AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED. A BATCH REVIEW WAS PERFORMED ON THE REPORTED LOT WITH NO DEVIATIONS FOUND.

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: THE ACTUAL SAMPLE WAS RECEIVED FOR EVALUATION. A BATCH REVIEW WAS CONDUCTED AND THERE WERE NO DEVIATIONS FOUND RELATED TO THIS REPORTED CONDITION DURING THE MANUFACTURE OF THIS LOT. DURING VISUAL INSPECTION AT THE MANUFACTURING FACILITY IT WAS IDENTIFIED THAT THE SAMPLE WAS TORN OPEN; CONFIRMING THE CUSTOMER REPORTED CONDITION. THE ROOT CAUSE HAS BEEN IDENTIFIED TO BE RELATED TO A MANUFACTURING DEFICIENCY. THIS ISSUE HAS BEEN ESCALATED TO CAPA.

Description of Event or Problem · 1

A CUSTOMER REPORTED TO BAXTER CORPORATE PRODUCT SURVEILLANCE AN UNKNOWN AMOUNT OF CLEARLINK Y-TYPE CATHETER EXTENSION SETS IN WHICH, WHEN ATTEMPTING TO PULL THE PACKAGING APART FROM ONE ANOTHER, THE PACKAGES WERE TORN OPEN. THEREFORE, THE STERILITY OF THE PRODUCT WAS COMPROMISED. ACCORDING TO THE REPORT, THE PERFORATION BETWEEN THE TWO PACKAGES WAS NOT AS DEFINED AS NORMAL. THE ALLEGED DEFECT OCCURRED BEFORE USE. THEREFORE, THERE WERE NO REPORTS OF PATIENT INVOLVEMENT, PATIENT INJURY, ADVERSE EVENTS, OR MEDICAL INTERVENTION. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS ADMINISTRATION, SET, INTRAVASCULAR FPA BAXTER HEALTHCARE R12H28075

Patients

Seq Age Sex Outcome Treatment
1